Eric Masson

Cucurbituril chemistry: a tale of supramolecular success

Eric Masson, Xiaoxi Ling, Roymon Joseph et al. · RSC Advances · 2011 · 935 citations

Natural Sciences, Biochemistry, Chemistry +12

A Phase I Study of Intravenous LBH589, a Novel Cinnamic Hydroxamic Acid Analogue Histone Deacetylase Inhibitor, in Patients with Refractory Hematologic Malignancies

Francis J. Giles, Thomas Fischer, Jörge E. Cortes et al. · Clinical Cancer Research · 2006 · 314 citations

Medicine, Hematology, Pharmacology +17

Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PTK787/ZK 222584 Administered Twice Daily in Patients With Advanced Cancer

Anne Thomas, Bruno Morgan, Mark A. Horsfield et al. · Journal of Clinical Oncology · 2005 · 226 citations

Medicine, Oncology, Pharmacology +17

Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo. A rationale for high-dose methotrexate.

Eric Masson, Mary V. Relling, Timothy W. Synold et al. · Journal of Clinical Investigation · 1996 · 207 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Phase I clinical and pharmacokinetic study of PTK/ZK, a multiple VEGF receptor inhibitor, in patients with liver metastases from solid tumours

K. Mross, Joachim Drevs, M Müller et al. · European Journal of Cancer · 2005 · 166 citations

Medicine, Oncology, Pharmacokinetics +17